Svb Wealth LLC Skye Bioscience, Inc. Transaction History

Svb Wealth LLC

  • $117 Million
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021
SELL
$0.09 - $0.25 $3,214 - $8,928
-35,714 Closed
0 $0
Q1 2021

May 11, 2021
BUY
$0.04 - $0.13 $1,428 - $4,642
35,714 New
35,714 $4,000

About Skye Bioscience, Inc.

SKYE Quotes by TradingView
  • Ticker SKYE
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 495,924,992
  • Market Cap $2.04B
  • Description
  • Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical t...
More about SKYE
Track This Portfolio

Track Svb Wealth LLC Portfolio

Follow Svb Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Svb Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Svb Wealth LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email